Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

In the version of this article originally published, there was an error in Fig. 2n. The top line of the HR comparison chart originally was Atezo + bev vs sun. It should have been Atezo + bev vs atezo. The error has been corrected in the HTML and PDF versions of this article.

Nature medicine. 2018 Oct 05 [Epub ahead of print]

David F McDermott, Mahrukh A Huseni, Michael B Atkins, Robert J Motzer, Brian I Rini, Bernard Escudier, Lawrence Fong, Richard W Joseph, Sumanta K Pal, James A Reeves, Mario Sznol, John Hainsworth, W Kimryn Rathmell, Walter M Stadler, Thomas Hutson, Martin E Gore, Alain Ravaud, Sergio Bracarda, Cristina Suárez, Riccardo Danielli, Viktor Gruenwald, Toni K Choueiri, Dorothee Nickles, Suchit Jhunjhunwala, Elisabeth Piault-Louis, Alpa Thobhani, Jiaheng Qiu, Daniel S Chen, Priti S Hegde, Christina Schiff, Gregg D Fine, Thomas Powles

Beth Israel Deaconess Medical Center, Boston, MA, USA. ., Genentech, Inc., South San Francisco, CA, USA., Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA., Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA., Gustave Roussy, Villejuif, France., University of California, San Francisco School of Medicine, San Francisco, CA, USA., Mayo Clinic Hospital -Florida, Jacksonville, FL, USA., City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Florida Cancer Specialists, Fort Myers, FL, USA., Yale School of Medicine, New Haven, CT, USA., Sarah Cannon Research Institute, Nashville, TN, USA., Vanderbilt University Medical Center, Nashville, TN, USA., University of Chicago Medicine, Chicago, IL, USA., Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA., Royal Marsden Hospital, London, UK., CHU Hopitaux de Bordeaux - Hôpital Saint-André, Bordeaux, France., Ospedale San Donato, Azienda USL Toscana Sudest, Arezzo, Italy., Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Azienda Ospedaliera Universitaria Senese, Center for Immune-Oncology, Siena, Italy., Medizinische Hochschule, Zentrum Innere Medizin, Abt. Hämatologie u. Onkologie, Hannover, Germany., Dana-Farber Cancer Institute, Boston, MA, USA., Roche Products Ltd, Welwyn Garden City, UK., Barts Cancer Institute and the Royal Free Hospital, Queen Mary University of London, London, UK.

email news signup